biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Quite The Change!

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 20, 2023 9:53pm

85 Views

Post# 35597295

RE:RE:RE:Quite The Change!

It's a generally good practice to pay attention in conversations, beenthere.

I'll be leaving the forum for a few weeks, again, beenthere. Should I inform you so you won't think I'm ignoring you?

<< Previous

Bullboard Posts

Next >>

How Canadian investors can benefit from flow-through shares